Fu Han

579 citations
9 papers · 488 · h-index 7

Impact in

  • Toxicology top 10%
    • Plant-derived Lignans Synthesis and Bioactivity
    • Cancer therapeutics and mechanisms
    • RNA Interference and Gene Delivery
    • DNA and Nucleic Acid Chemistry
    • Advanced biosensing and bioanalysis techniques
    • Biological Activity of Diterpenoids and Biflavonoids

Papers in

    • Cancer therapeutics and mechanisms 4
    • Angiogenesis and VEGF in Cancer 1
    • Synthesis and Biological Evaluation 4
    • Synthesis and biological activity 2

Fu Han

9 papers receiving 472 citations

Peers

Fu Han
Comparison fields: 5 of 58
  • Toxicology 21
  • Molecular Biology 419
  • Organic Chemistry 140
  • Virology 12
  • Cancer Research 35
Replace Kyle W. Sherrill with:
Kyle W. Sherrill United States
Devyani Haldar India
Susan M. Boyd United Kingdom
Omar Moukha‐Chafiq United States
Matthew Feldhammer United States
Taiane Schneider Spain
Konstantin Akopiants United States
Agnieszka Krakowiak Poland
Kristoffer Brandvold United States
Peter Hecht Austria
Fu Han relative to Kyle W. Sherrill United States Kyle W. Sherrill's profile →
Citations per field
00.5×6.4×
Kyle W. Sherrill · 1×
Citations per year

Countries citing papers authored by Fu Han

Since Specialization
Citations

This map shows the geographic impact of Fu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Han more than expected).

Fields of papers citing papers by Fu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Han. The network helps show where Fu Han may publish in the future.

Co-authors

The 25 scholars most cited alongside Fu Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fu Han Line = papers co-authored together Fu Han links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 1992195
2 199095
3 199076
4
Effect of 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants.
199133
5 198631
6 201731
7 201619
8 20245
9
[Time course of calpain activity changes in rat neurons following fluid percussion injury and the interventional effect of mild hypothermia].
20073

About Fu Han

Fu Han is a scholar working on Molecular Biology, Organic Chemistry, Automotive Engineering, Critical Care and Intensive Care Medicine and Neurology, having authored 9 papers that have together received 488 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Synthesis and Biological Evaluation (4 papers), Synthesis and biological activity (2 papers), MicroRNA in disease regulation (1 paper), Electric Vehicles and Infrastructure (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Transportation and Mobility Innovations (1 paper) and Traumatic Brain Injury and Neurovascular Disturbances (1 paper). The work is most often cited by research in Toxicology (21 citations), Molecular Biology (419 citations), Organic Chemistry (140 citations), Virology (12 citations) and Cancer Research (35 citations). Fu Han has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Weiyi Gao, C. B. Storm, Yi-Ting Cheng, William Egan, Kuo Hsiung Lee, Dora M. Schnur, J. Phillip Bowen, Li Li, Scott A. Beers and Masami Mori. Their work appears in journals such as Journal of Medicinal Chemistry, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Molecular Pharmacology, CNS & Neurological Disorders - Drug Targets and Frontiers in Energy Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact